BDBM509773 US20200361871A1, Example 92.2

SMILES CC(C)(NC(=O)c1cc(NC(=O)Cc2ccc(Cl)c(O)c2)ccn1)C#C

InChI Key InChIKey=KTRJIUHBRNTCIR-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 509773   

TargetAnoctamin-1(Human)
Enterprise Therapeutics

US Patent
LigandPNGBDBM509773(US20200361871A1, Example 92.2)
Affinity DataEC50:  10nMAssay Description:Compound activity was quantified by measuring the increase in current upon compound addition and expressing this as a percentage increase of baseline...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/13/2022
Entry Details
US Patent